Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC16A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RYBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2N - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DRAM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EXOSC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HSD17B8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EPM2AIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPIF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EED - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRDX5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DERL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPS16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTRHD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CELF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADAMTS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PEBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C3orf52 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on